Stock HSCS HEART TEST LABORATORIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Heart Test Laboratories, Inc.

Equities

HSCS

US42254E3027

Market Closed - Nasdaq
Other stock markets
 21:30:00 24/06/2024 BST 		5-day change 1st Jan Change
5.55 USD +5.71% Intraday chart for Heart Test Laboratories, Inc. +4.91% -67.54%
04-24 HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG CI
03-26 HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HeartSciences Regains Compliance with Nasdaq Listing Requirements
AQ
HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio
AQ
HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG
GL
HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG
CI
HeartSciences to Present at the LD Micro Invitational XIV Conference
GL
HeartSciences to Present at the LD Micro Invitational XIV Conference
AQ
HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients
GL
HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients
CI
HeartSciences Reports Third Quarter Fiscal 2024 Financial Results
GL
Heart Test Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024
CI
HeartSciences’ Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes
GL
HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology
GL
HeartSciences Adds Key Advisor to its Scientific Advisory Board
GL
HeartSciences Adds Key Advisor to its Scientific Advisory Board
AQ
Heart Test Laboratories, Inc. Appoints Partho P. Sengupta to Its Scientific Advisory Board
CI
HeartSciences Expands its Scientific Advisory Board
GL
Heart Test Laboratories, Inc. Appoints Jordan B. Strom to Its Scientific Advisory Board
CI
HeartSciences Appoints New Scientific Advisory Board Member
GL
HeartSciences Appoints New Scientific Advisory Board Member
AQ
HeartSciences Appoints Benjamin Glicksberg to its Scientific Advisory Board
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HSCS Stock
  4. News Heart Test Laboratories, Inc.